Exelixis
EXEL
#1765
Rank
$11.26 B
Marketcap
$41.84
Share price
-0.78%
Change (1 day)
18.97%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company